Injection Site Tolerability, Safety, Pharmacokinetics, Pharmacodynamics in Different Single-Dose Treatments of Alirocumab SAR236553 (REGN727) in Healthy Subjects
Clinical trial NCT01443650 · COMPLETED
Trial details
- NCT number
- NCT01443650
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2011-11-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.